FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Amalio Telenti

Research Profile

Disorders

HIV Infections

Living Beings

HIV-1

Chemicals & Drugs

Concepts & Ideas

Procedures

Geographic Areas

Switzerland

Physiology

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Occupations

Pharmacogenetics

Co-author Network

Publications

TOP 3
Manel Aouri; Thierry Buclin; Alexandra Calmy; Matthias Cavassini; Bernard Hirschel; Andri Rauch; Amalio Telenti; Laurent A Decosterd
A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients.
Angela Ciuffi; Amalio Telenti
State of genomics and epigenomics research in the perspective of HIV cure.
Pejman Mohammadi; Miguel Muñoz; Amalio Telenti; Nadine Zangger; István Bartha; Niko Beerenwinkel; Sébastien Desfarges; Huldrych F Günthard; Beda Joos; Angela Ciuffi
24 hours in the life of HIV-1 in a T cell line.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Amalio Telenti (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Manel Aouri; Thierry Buclin; Alexandra Calmy; Matthias Cavassini; Bernard Hirschel; Andri Rauch; Amalio Telenti; Laurent A Decosterd
A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients.
Journal of mass spectrometry : JMS 2013;48(5):616-25.
2013: Angela Ciuffi; Amalio Telenti
State of genomics and epigenomics research in the perspective of HIV cure.
Current opinion in HIV and AIDS 2013;8(3):176-81.
2013: Pejman Mohammadi; Miguel Muñoz; Amalio Telenti; Nadine Zangger; István Bartha; Niko Beerenwinkel; Sébastien Desfarges; Huldrych F Günthard; Beda Joos; Angela Ciuffi
24 hours in the life of HIV-1 in a T cell line.
PLoS pathogens 2013;9(1):e1003161.
2013: Rubin Lubomirov; Raquel Martinez; Catia Marzolini; Margalida Rotger; Amalio Telenti; Mona Arab-Alameddine; Enos Bernasconi; Thierry Buclin; Alexandra Calmy; Matthias Cavassini; Chantal Csajka; Laurent A Decosterd; Julia di Iulio; Aurélie Fayet-Mello; Hansjakob Furrer; Monia Guidi; Huldrych F Günthard
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals.
Pharmacogenetics and genomics 2013;23(1):9-18.
2013: Aurélie Fayet-Mello; Claudia Grawe; Erika Gremlich; Nicole Guignard; Begoña Martinez de Tejada; Karoline Aebi Popp; Flavia Schmid; Amalio Telenti; Jérôme Biollaz; Thierry Buclin; Matthias Cavassini; Sandra Cruchon; Laurent A Decosterd; Chin B Eap
Free and total plasma levels of lopinavir during pregnancy, at delivery and postpartum: implications for dosage adjustments in pregnant women.
Antiviral therapy 2013;18(2):171-82.
2012: Melanie A Thompson; Judith A Aberg; Constance Benson; Pedro Cahn; Joseph J Eron; Huldrych F Günthard; Scott M Hammer; Jennifer F Hoy; Donna M Jacobsen; Peter Reiss; Douglas D Richman; Giuliano Rizzardini; Amalio Telenti; David L Thomas; Paul A Volberding
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.
JAMA : the journal of the American Medical Association 2012;308(4):387-402.
2012: Mona Arab-Alameddine; Marta Boffito; Thierry Buclin; Matthias Cavassini; Chantal Csajka; Laurent A Decosterd; Julia di Iulio; Aurélie Fayet-Mello; Huldrych Günthard; Rubin Lubomirov; Michael Neely; Andrew Owen; Katharina Rentsch; Margalida Rotger; Amalio Telenti; Manel Aouri
Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individuals.
Antimicrobial agents and chemotherapy 2012;56(6):2959-66.
2012: Amalio Telenti; Welkin E Johnson
Host genes important to HIV replication and evolution.
Cold Spring Harbor perspectives in medicine 2012;2(4):a007203.
2012: Nadia Rahm; Amalio Telenti
The role of tripartite motif family members in mediating susceptibility to HIV-1 infection.
Current opinion in HIV and AIDS 2012;7(2):180-6.
2012: Nadine Laguette; Jan Münch; Nadia Rahm; Daniel Sauter; Joke Snoeck; Bijan Sobhian; William M Switzer; Amalio Telenti; Christine Chable-Bessia; Frederic Delsuc; Walid Heneine; Frank Kirchhoff; Monsef Benkirane
Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein.
Cell host & microbe 2012;11(2):205-17.
2012: Nuria Izquierdo-Useros; Oliver T Keppler; Hans-Georg Kräusslich; Maier Lorizate; Bonaventura Clotet; Elina Erikson; Itziar Erkizia; Bärbel Glass; Maria Pino; Maria C Puertas; Maria T Rodriguez-Plata; Amalio Telenti; Nadine Zangger; Javier Martinez-Picado
Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides.
PLoS biology 2012;10(12):e1001448.
2012: M Guidi; Margalida Rotger; Amalio Telenti; Manel Aouri; Mona Arab-Alameddine; Thierry Buclin; Chantal Csajka; Laurent A Decosterd
Dosage optimization of treatments using population pharmacokinetic modeling and simulation.
Chimia 2012;66(5):291-5.
2012: Emilie Zuercher; Manuel Battegay; Emmanuelle Boffi El Amari; Christophe Butticaz; Thanh Dang; Jean-François Egger; Jan Fehr; Raquel Martinez; Esther Mueller-Garamvögyi; Andrea Parini; Sylvia Rothenberger; Stephan C Schaefer; Franziska Schoeni-Affolter; Amalio Telenti; Christine Thurnheer; Marianne Tinguely; Josiane Wyniger
Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activation.
PloS one 2012;7(2):e32168.
2012: María Pernas; Lidia Ruiz; Jorge Sánchez; Víctor Sánchez-Merino; Amalio Telenti; José L Vicario; Eloísa Yuste; Carolina Arcones; Christian Brander; Concepcion Casado; Eulalia Grau; Anuska Llano; Beatriz Mothe; Cecilio López- Galíndez
Low-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controller.
PloS one 2012;7(2):e31928.
2012: Tracy R Glass; Huldrych Günthard; Bernard Hirschel; Catia Marzolini; Dunja Nicca; Martin Rickenbach; Margalida Rotger; Amalio Telenti; Gilles Wandeler; Manuel Battegay; Enos Bernasconi; Heiner C Bucher; Chantal Csajka; Laurent A Decosterd
Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
PloS one 2012;7(1):e29186.
2011: Gary J Vanasse; Damon Anderson; Harini Bathulapalli; Jacques Fellay; Mark Fleming; Jee-Yeong Jeong; Amy C Justice; Kristin Mattocks; Hanno Steen; Janet Tate; Amalio Telenti; Nancy Berliner
A polymorphism in the leptin gene promoter is associated with anemia in patients with HIV disease.
Blood 2011;118(20):5401-8.
2011: Aurélie Fayet Mello; Claudia Franc; Nicole Guignard; Amalio Telenti; Jérôme Biollaz; Thierry Buclin; Sara Colombo; Sandra Cruchon; Laurent A Decosterd; Matthias Cavassini
Cell disposition of raltegravir and newer antiretrovirals in HIV-infected patients: high inter-individual variability in raltegravir cellular penetration.
The Journal of antimicrobial chemotherapy 2011;66(7):1573-81.
2011: Gregory Lefebvre; Miguel Muñoz; Jacques Rougemont; Amalio Telenti; Frédéric Uyttebroeck; Niko Beerenwinkel; Sébastien Desfarges; Angela Ciuffi
Analysis of HIV-1 expression level and sense of transcription by high-throughput sequencing of the infected cell.
Journal of virology 2011;85(13):6205-11.
2011: Margalida Rotger; Judith Dalmau; Andri Rauch; Paul McLaren; Steven E Bosinger; Raquel Martinez; Netanya G Sandler; Annelys Roque; Julia Liebner; Manuel Battegay; Enos Bernasconi; Patrick Descombes; Itziar Erkizia; Jacques Fellay; Bernard Hirschel; Jose M Miró; Eduard Palou; Matthias Hoffmann; Marta Massanella; Julià Blanco; Matthew Woods; Huldrych F Günthard; Paul de Bakker; Daniel C Douek; Guido Silvestri; Javier Martinez-Picado; Amalio Telenti
Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque.
The Journal of clinical investigation 2011;121(6):2391-400.
2011: Evangelos Evangelou; Jacques Fellay; Sara Colombo; Javier Martinez-Picado; Niels Obel; David B Goldstein; Amalio Telenti; John Ioannidis
Impact of phenotype definition on genome-wide association signals: empirical evaluation in human immunodeficiency virus type 1 infection.
American journal of epidemiology 2011;173(11):1336-42.
2011: Vincent Thomas; Claire Bertelli; François Collyn; Nicola Casson; Amalio Telenti; Alexander Goesmann; Antony Croxatto; Gilbert Greub
Lausannevirus, a giant amoebal virus encoding histone doublets.
Environmental microbiology 2011;13(6):1454-66.
2011: Julia di Iulio; Angela Ciuffi; Karen Fitzmaurice; Dermot Kelleher; Margalida Rotger; Jacques Fellay; Raquel Martinez; Sara Pulit; Hansjakob Furrer; Huldrych Günthard; Manuel Battegay; Enos Bernasconi; Patrick Schmid; Bernard Hirschel; Eleanor Barnes; Paul Klenerman; Amalio Telenti; Andri Rauch
Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance.
Hepatology (Baltimore, Md.) 2011;53(5):1446-54.
2011: Nadia Rahm; Melvyn Yap; Joke Snoeck; Vincent Zoete; Miguel Muñoz; Ute Radespiel; Elke Zimmermann; Olivier Michielin; Jonathan P Stoye; Angela Ciuffi; Amalio Telenti
Unique spectrum of activity of prosimian TRIM5alpha against exogenous and endogenous retroviruses.
Journal of virology 2011;85(9):4173-83.
2011: Smita Kulkarni; Ram Savan; Ying Qi; Xiaojiang Gao; Yuko Yuki; Sara E Bass; Maureen P Martin; Peter Hunt; Steven G Deeks; Amalio Telenti; Florencia Pereyra; David Goldstein; Steven Wolinsky; Bruce Walker; Howard A Young; Mary Carrington
Differential microRNA regulation of HLA-C expression and its association with HIV control.
Nature 2011;472(7344):495-8.
2011: Millán Ortiz; Estella S Poloni; Hansjakob Furrer; Helen Kovari; Raquel Martinez; Mireia Arnedo; Luigia Elzi; Enos Bernasconi; Pietro Vernazza; Bernard Hirschel; Matthias Cavassini; bruno ledergerber; Huldrych Günthard; Amalio Telenti; Philip E Tarr
No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy.
The Journal of infectious diseases 2011;203(5):620-4.
2011: Francois Vigneault; Matthew Woods; Maria J Buzon; Chun Li; Florencia Pereyra; Seth D Crosby; Jenna Rychert; George Church; Javier Martinez-Picado; Eric S Rosenberg; Amalio Telenti; Xu G Yu; Mathias Lichterfeld
Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
Journal of virology 2011;85(6):3015-9.
2011: Yannick Bulliard; Inigo Narvaiza; Alessandro Bertero; Shyam Peddi; Ute F Röhrig; Millán Ortiz; Vincent Zoete; Nataly Castro-Díaz; Priscilla Turelli; Amalio Telenti; Olivier Michielin; Matthew D Weitzman; Didier Trono
Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities.
Journal of virology 2011;85(4):1765-76.
2011: Rubin Lubomirov; Sara Colombo; Julia di Iulio; bruno ledergerber; Raquel Martinez; Matthias Cavassini; Bernard Hirschel; Enos Bernasconi; Luigia Elzi; Pietro Vernazza; Hansjakob Furrer; Huldrych Günthard; Amalio Telenti
Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study.
The Journal of infectious diseases 2011;203(2):246-57.
2011: Joke Snoeck; István Bartha; Daniel C Douek; Jacques Fellay; Amalio Telenti
Mapping of positive selection sites in the HIV-1 genome in the context of RNA and protein structural constraints.
Retrovirology 2011;8():87.
2011: Thierry Buclin; Amalio Telenti; Rafael Perera; Chantal Csajka; Hansjakob Furrer; Jeffrey K Aronson; Paul P Glasziou
Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy.
PloS one 2011;6(4):e18578.
2011: Aurélie Fayet Mello; Thierry Buclin; Laurent A Decosterd; Cécile Delhumeau; Julia di Iulio; Alessandra Fleurent; Marie-Paule Schneider; Matthias Cavassini; Amalio Telenti; Bernard Hirschel; Alexandra Calmy
Successful efavirenz dose reduction guided by therapeutic drug monitoring.
Antiviral therapy 2011;16(2):189-97.
2010: Silke Paust; Harvinder S Gill; Bao-Zhong Wang; Michael P Flynn; E Ashley Moseman; Balimkiz Senman; Marian Szczepanik; Amalio Telenti; Philip W Askenase; Richard W Compans; Ulrich H von Andrian
Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses.
Nature immunology 2010;11(12):1127-35.
2010: Amalio Telenti; Paul McLaren
Genomic approaches to the study of HIV‐1 acquisition.
The Journal of infectious diseases 2010;202 Suppl 3():S382-6.
2010: Margalida Rotger; Thomas Gsponer; Raquel Martinez; Patrick Taffé; Luigia Elzi; Pietro Vernazza; Matthias Cavassini; Enos Bernasconi; Bernard Hirschel; Hansjakob Furrer; Rainer Weber; bruno ledergerber; Matthias Egger; Amalio Telenti; Philip E Tarr
Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;51(9):1090-8.
2010: Franziska Schoeni-Affolter; bruno ledergerber; Martin Rickenbach; Christoph Rudin; Huldrych F Günthard; Amalio Telenti; Hansjakob Furrer; Sabine Yerly; Patrick Francioli
Cohort profile: the Swiss HIV Cohort study.
International journal of epidemiology 2010;39(5):1179-89.
2010: Paul I W de Bakker; Amalio Telenti
Infectious diseases not immune to genome-wide association.
Nature genetics 2010;42(9):731-2.
2010: Janine Rohrbach; Nicola Robinson; Gillian Harcourt; Emma Hammond; Silvana Gaudieri; Meri Gorgievski; Amalio Telenti; Olivia Keiser; Huldrych F Günthard; Bernhard Hirschel; Matthias Hoffmann; Enos Bernasconi; Manuel Battegay; Hansjakob Furrer; Paul Klenerman; Andri Rauch
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.
Gut 2010;59(9):1252-8.
2010: Melanie A Thompson; Judith A Aberg; Pedro Cahn; Julio S G Montaner; Giuliano Rizzardini; Amalio Telenti; José M Gatell; Huldrych F Günthard; Scott M Hammer; Martin S Hirsch; Donna M Jacobsen; Peter Reiss; Douglas D Richman; Paul A Volberding; Patrick Yeni; Robert T Schooley
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.
JAMA : the journal of the American Medical Association 2010;304(3):321-33.
2010: Anke Specht; Amalio Telenti; Raquel Martinez; Jacques Fellay; Elizabeth Bailes; David T Evans; Mary Carrington; Beatrice H Hahn; David B Goldstein; Frank Kirchhoff
Counteraction of HLA-C-mediated immune control of HIV-1 by Nef.
Journal of virology 2010;84(14):7300-11.
2010: Philip E Tarr; Margalida Rotger; Amalio Telenti
Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics.
Pharmacogenomics 2010;11(4):587-94.
2010: Ester Ballana; Jordi Senserrich; Eduardo Pauls; Rosa Faner; Josep Maria Mercader; Frédéric Uyttebroeck; Eduard Palou; Maria Pau Mena; Eulalia Grau; Bonaventura Clotet; Lidia Ruiz; Amalio Telenti; Angela Ciuffi; José A Esté
ZNRD1 (zinc ribbon domain-containing 1) is a host cellular factor that influences HIV-1 replication and disease progression.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(7):1022-32.
2010: Olivier Clerc; Sara Colombo; Sabine Yerly; Amalio Telenti; Matthias Cavassini
HIV-1 elite controllers: beware of super-infections.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2010;47(4):376-8.
2010: Rubin Lubomirov; Julia di Iulio; Aurélie Fayet; Sara Colombo; Raquel Martinez; Catia Marzolini; Hansjakob Furrer; Pietro Vernazza; Alexandra Calmy; Matthias Cavassini; bruno ledergerber; Katharina Rentsch; Patrick Descombes; Thierry Buclin; Laurent A Decosterd; Chantal Csajka; Amalio Telenti
ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir.
Pharmacogenetics and genomics 2010;20(4):217-30.
2010: Andri Rauch; Zoltan Kutalik; Patrick Descombes; Tao Cai; Julia Di Iulio; Tobias Mueller; Murielle Bochud; Manuel Battegay; Enos Bernasconi; Jan Borovicka; Sara Colombo; Andreas Cerny; Jean-François Dufour; Hansjakob Furrer; Huldrych F Günthard; Markus Heim; Bernard Hirschel; Raffaele Malinverni; Darius Moradpour; Beat Müllhaupt; Andrea Witteck; Jacques Beckmann; Thomas Berg; Sven Bergmann; Francesco Negro; Amalio Telenti; Pierre-Yves Bochud
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.
Gastroenterology 2010;138(4):1338-45, 1345.e1-7.
2010: Margalida Rotger; Kristen K Dang; Jacques Fellay; Erin L Heinzen; Sheng Feng; Patrick Descombes; Kevin V Shianna; Dongliang Ge; Huldrych F Günthard; David B Goldstein; Amalio Telenti
Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals.
PLoS pathogens 2010;6(2):e1000781.
2010: Philip E Tarr; Amalio Telenti
Genetic screening for metabolic and age-related complications in HIV-infected persons.
F1000 medicine reports 2010;2():83.
2010: Jacques Fellay; Kevin V Shianna; Amalio Telenti; David B Goldstein
Host genetics and HIV-1: the final phase?
PLoS pathogens 2010;6(10):e1001033.
2010: Samuel Alizon; Viktor von Wyl; Tanja Stadler; Roger D Kouyos; Sabine Yerly; Bernard Hirschel; Jürg Böni; Cyril Shah; Thomas Klimkait; Hansjakob Furrer; Andri Rauch; Pietro L Vernazza; Enos Bernasconi; Manuel Battegay; Philippe Bürgisser; Amalio Telenti; Huldrych F Günthard; Sebastian Bonhoeffer
Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load.
PLoS pathogens 2010;6(9):e1001123.
2010: Concepcion Casado; Sara Colombo; Andri Rauch; Raquel Martínez; Huldrych F Günthard; Soledad Garcia; Carmen Rodríguez; Jorge del Romero; Amalio Telenti; Cecilio López-Galíndez
Host and viral genetic correlates of clinical definitions of HIV-1 disease progression.
PloS one 2010;5(6):e11079.
2009: Margalida Rotger; Cornelia Bayard; Patrick Taffé; Raquel Martinez; Matthias Cavassini; Enos Bernasconi; Manuel Battegay; Bernard Hirschel; Hansjakob Furrer; Andrea Witteck; Rainer Weber; bruno ledergerber; Amalio Telenti; Philip E Tarr
Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.
Circulation. Cardiovascular genetics 2009;2(6):621-8.
2009: Rasmi Thomas; Richard Apps; Ying Qi; Xiaojiang Gao; Victoria Male; Colm O'hUigin; Geraldine O'Connor; Dongliang Ge; Jacques Fellay; Jeffrey N Martin; Joseph B Margolick; James J Goedert; Susan Buchbinder; Gregory D Kirk; Maureen P Martin; Amalio Telenti; Steven G Deeks; Bruce D Walker; David Goldstein; Daniel W McVicar; Ashley Moffett; Mary Carrington
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C.
Nature genetics 2009;41(12):1290-4.
2009: Millán Ortiz; Nicolas Guex; Etienne Patin; Olivier Martin; Ioannis Xenarios; Angela Ciuffi; Lluís Quintana-Murci; Amalio Telenti
Evolutionary trajectories of primate genes involved in HIV pathogenesis.
Molecular biology and evolution 2009;26(12):2865-75.
2009: Thomas J Urban; Amy C Weintrob; Jacques Fellay; Sara Colombo; Kevin V Shianna; Curtis Gumbs; Margalida Rotger; Kimberly Pelak; Kristen K Dang; Roger Detels; Jeremy J Martinson; Stephen J O'Brien; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Mary Carrington; Amalio Telenti; Nelson L Michael; David B Goldstein
CCL3L1 and HIV/AIDS susceptibility.
Nature medicine 2009;15(10):1110-2.
2009: M Arab-Alameddine; J Di Iulio; Thierry Buclin; Margalida Rotger; R Lubomirov; M Cavassini; A Fayet; Laurent A Décosterd; Chin B Eap; Jérôme Biollaz; Amalio Telenti; Chantal Csajka
Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals.
Clinical pharmacology and therapeutics 2009;85(5):485-94.
2009: A Fayet; A Béguin; Boris Zanolari; S Cruchon; N Guignard; Amalio Telenti; Matthias Cavassini; Huldrych Günthard; Thierry Buclin; Jérôme Biollaz; Bertrand Rochat; Laurent A Decosterd
A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2009;877(11-12):1057-69.
2009: Amalio Telenti
Time (again) for a randomized trial of pharmacogenetics of antiretroviral therapy.
Pharmacogenomics 2009;10(4):515-6.
2009: Julia di Iulio; Aurélie Fayet; Mona Arab-Alameddine; Margalida Rotger; Rubin Lubomirov; Matthias Cavassini; Hansjakob Furrer; Huldrych F Günthard; Sara Colombo; Chantal Csajka; Chin B Eap; Laurent A Decosterd; Amalio Telenti
In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function.
Pharmacogenetics and genomics 2009;19(4):300-9.
2009: Amalio Telenti
Safety concerns about CCR5 as an antiviral target.
Current opinion in HIV and AIDS 2009;4(2):131-5.
2009: Olivier Martin; Armand Valsesia; Amalio Telenti; Ioannis Xenarios; Brian J Stevenson
AssociationViewer: a scalable and integrated software tool for visualization of large-scale variation data in genomic context.
Bioinformatics (Oxford, England) 2009;25(5):662-3.
2009: Amalio Telenti
HIV-1 host interactions: integration of large-scale datasets.
F1000 biology reports 2009;1():71.
2009: C Bellini; Olivia Keiser; J-P Chave; Jm Evison; J Fehr; L Kaiser; Rainer Weber; Pietro Vernazza; Enos Bernasconi; Amalio Telenti; M Cavassini
Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study.
HIV medicine 2009;10(1):12-8.
2008: Kayole Kazadi; Corinne Loeuillet; Samuel Deutsch; Angela Ciuffi; Miguel Muñoz; Jacques Beckmann; Darius Moradpour; Stylianos E Antonarakis; Amalio Telenti
Genomic determinants of the efficiency of internal ribosomal entry sites of viral and cellular origin.
Nucleic acids research 2008;36(21):6918-25.
2008: Sara Colombo; Andri Rauch; Margalida Rotger; Jacques Fellay; Raquel Martinez; Christoph Fux; Christine Thurnheer; Huldrych Günthard; David B Goldstein; Hansjakob Furrer; Amalio Telenti
The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir.
The Journal of infectious diseases 2008;198(6):864-7.
2008: Millan Ortiz; Henrik Kaessmann; K Zhang; A Bashirova; M Carrington; L Quintana-Murci; Amalio Telenti
The evolutionary history of the CD209 (DC-SIGN) family in humans and non-human primates.
Genes and immunity 2008;9(6):483-92.
2008: Aurélie Fayet; Alexandre Béguin; Begona Martinez de Tejada; Sara Colombo; Matthias Cavassini; Stefan Gerber; Chin B Eap; Amalio Telenti; Thierry Buclin; Jérôme Biollaz; Laurent A Decosterd
Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fraction.
Therapeutic drug monitoring 2008;30(4):511-22.
2008: Andri Rauch; David Nolan; Hansjakob Furrer; Elizabeth McKinnon; Mina John; Simon Mallal; Silvana Gaudieri; Huldrych F Günthard; Patrick Schmid; Manuel Battegay; Bernard Hirschel; Amalio Telenti; Ian James
HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(12):1921-5.
2008: Rubin Lubomirov; Amalio Telenti; Margalida Rotger
[General concepts and study methods in pharmacogenetics].
Enfermedades infecciosas y microbiología clínica 2008;26 Suppl 6():4-9.
2008: Dongliang Ge; Kunlin Zhang; Anna C Need; Olivier Martin; Jacques Fellay; Thomas J Urban; Amalio Telenti; David B Goldstein
WGAViewer: software for genomic annotation of whole genome association studies.
Genome research 2008;18(4):640-3.
2008: Margalida Rotger; Amalio Telenti
Optimizing efavirenz treatment: CYP2B6 genotyping or therapeutic drug monitoring?
European journal of clinical pharmacology 2008;64(4):335-6.
2008: Valérie Goldschmidt; Angela Ciuffi; Millan Ortiz; David Brawand; Miguel Muñoz; Henrik Kaessmann; Amalio Telenti
Antiretroviral activity of ancestral TRIM5alpha.
Journal of virology 2008;82(5):2089-96.
2008: Corinne Loeuillet; Samuel Deutsch; Angela Ciuffi; Daniel Robyr; Patrick Taffé; Miguel Muñoz; Jacques Beckmann; Stylianos E Antonarakis; Amalio Telenti
In vitro whole-genome analysis identifies a susceptibility locus for HIV-1.
PLoS biology 2008;6(2):e32.
2008: Amalio Telenti; Mary Carrington
Host factors associated with outcome from primary human immunodeficiency virus-1 infection.
Current opinion in HIV and AIDS 2008;3(1):28-35.
2007: Corinne Loeuillet; Michael Weale; Samuel Deutsch; Margalida Rotger; Nicole Soranzo; Josiane Wyniger; Guillaume Lettre; Yann Dupré; Delphine Thuillard; Jacques Beckmann; Stylianos E Antonarakis; David B Goldstein; Amalio Telenti
Promoter polymorphisms and allelic imbalance in ABCB1 expression.
Pharmacogenetics and genomics 2007;17(11):951-9.
2007: Margalida Rotger; Maria Saumoy; Kunlin Zhang; Markus Flepp; Roland Sahli; Laurent A Decosterd; Amalio Telenti
Partial deletion of CYP2B6 owing to unequal crossover with CYP2B7.
Pharmacogenetics and genomics 2007;17(10):885-90.
2007: Viktor von Wyl; Sabine Yerly; Jürg Böni; Philippe Bürgisser; Thomas Klimkait; Manuel Battegay; Hansjakob Furrer; Amalio Telenti; Bernard Hirschel; Pietro L Vernazza; Enos Bernasconi; Martin Rickenbach; Luc Perrin; bruno ledergerber; Huldrych Günthard
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types.
Archives of internal medicine 2007;167(16):1782-90.
2007: Mireia Arnedo; Patrick Taffé; Roland Sahli; Hansjakob Furrer; Bernard Hirschel; Luigia Elzi; Rainer Weber; Pietro Vernazza; Enos Bernasconi; Roger Darioli; Sven Bergmann; Jacques Beckmann; Amalio Telenti; Philip E Tarr
Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.
Pharmacogenetics and genomics 2007;17(9):755-64.
2007: Jacques Fellay; Kevin V Shianna; Dongliang Ge; Sara Colombo; bruno ledergerber; Mike Weale; Kunlin Zhang; Curtis Gumbs; Antonella Castagna; Andrea Cossarizza; Alessandro Cozzi-Lepri; Andrea De Luca; Philippa Easterbrook; Patrick Francioli; Simon Mallal; Javier Martinez-Picado; Jose M Miro; Niels Obel; Jason P Smith; Josiane Wyniger; Patrick Descombes; Stylianos E Antonarakis; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Amalio Telenti; David B Goldstein
A whole-genome association study of major determinants for host control of HIV-1.
Science (New York, N.Y.) 2007;317(5840):944-7.
2007: Pierre-Yves Bochud; Murielle Bochud; Amalio Telenti; Thierry Calandra
Innate immunogenetics: a tool for exploring new frontiers of host defence.
The Lancet infectious diseases 2007;7(8):531-42.
2007: José A Esté; Amalio Telenti
HIV entry inhibitors.
Lancet 2007;370(9581):81-8.
2007: Rubin Lubomirov; Chantal Csajka; Amalio Telenti
ADME pathway approach for pharmacogenetic studies of anti-HIV therapy.
Pharmacogenomics 2007;8(6):623-33.
2007: Maureen P Martin; Ying Qi; Xiaojiang Gao; Eriko Yamada; Jeffrey N Martin; Florencia Pereyra; Sara Colombo; Elizabeth E Brown; W Lesley Shupert; John Phair; James J Goedert; Susan Buchbinder; Gregory D Kirk; Amalio Telenti; Mark Connors; Stephen J O'Brien; Bruce D Walker; Peter Parham; Steven G Deeks; Daniel W McVicar; Mary Carrington
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.
Nature genetics 2007;39(6):733-40.
2007: A Rauch; Rebecca Laird; Elizabeth J McKinnon; Amalio Telenti; H Furrer; R Weber; D Smillie; Silvana Gaudieri
Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection.
Tissue antigens 2007;69 Suppl 1():237-40.
2007: Margalida Rotger; Heike Tegude; Sara Colombo; M Cavassini; Hansjakob Furrer; Laurent A Décosterd; Julia Blievernicht; Tanja Saussele; Huldrych Günthard; Matthias Schwab; Michel Eichelbaum; Amalio Telenti; Uli Zanger
Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals.
Clinical pharmacology and therapeutics 2007;81(4):557-66.
2007: Pierre-Yves Bochud; Martin Hersberger; Patrick Taffé; Murielle Bochud; Catherine M Stein; Stephanie D Rodrigues; Thierry Calandra; Patrick Francioli; Amalio Telenti; Roberto F Speck; Alan Aderem
Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection.
AIDS (London, England) 2007;21(4):441-6.
2007: Christophe Butticaz; Olivier Michielin; Josiane Wyniger; Amalio Telenti; Sylvia Rothenberger
Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation.
Journal of virology 2007;81(3):1502-5.
2007: Olivia Keiser; Jacques Fellay; Milos Opravil; Hans Hirsch; Bernard Hirschel; Enos Bernasconi; Pietro L Vernazza; Martin Rickenbach; Amalio Telenti; Hansjakob Furrer
Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification.
Antiviral therapy 2007;12(8):1157-64.
2007: Philip E Tarr; Amalio Telenti
Toxicogenetics of antiretroviral therapy: genetic factors that contribute to metabolic complications.
Antiviral therapy 2007;12(7):999-1013.
2007: Margalida Rotger; Sara Colombo; Hansjakob Furrer; Laurent A Décosterd; Thierry Buclin; Amalio Telenti
Does tenofovir influence efavirenz pharmacokinetics?
Antiviral therapy 2007;12(1):115-8.
2007: Amalio Telenti; Matthias Egger
Identifying safety concerns from genetic data: lessons from the development of CCR5 inhibitors.
Antiviral therapy 2007;12(2):147-8.
2007: Kun-Lin Zhang; Bastien Mangeat; Millan Ortiz; Vincent Zoete; Didier Trono; Amalio Telenti; Olivier Michielin
Model structure of human APOBEC3G.
PloS one 2007;2(4):e378.
2006: Silvana Gaudieri; Andri Rauch; Lawrence Park; Elizabeth M Freitas; Susan Herrmann; Gary Jeffrey; Wendy Cheng; Katja Pfafferott; Kiloshni Naidoo; Russell Chapman; Manuel Battegay; Rainer Weber; Amalio Telenti; Hansjakob Furrer; Ian James; Michaela Lucas; Simon Mallal
Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection.
Journal of virology 2006;80(22):11094-104.
2006: Amalio Telenti; David B Goldstein
Genomics meets HIV-1.
Nature reviews. Microbiology 2006;4(11):865-73.
2006: Sara Colombo; Thierry Buclin; Matthias Cavassini; Laurent A Décosterd; Amalio Telenti; Jérôme Biollaz; Chantal Csajka
Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infection.
Antimicrobial agents and chemotherapy 2006;50(11):3801-8.
2006: Sara Colombo; Thierry Buclin; Laurent A Décosterd; Amalio Telenti; Hansjakob Furrer; Belle L Lee; Jérôme Biollaz; Chin B Eap
Orosomucoid (alpha1-acid glycoprotein) plasma concentration and genetic variants: effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation.
Clinical pharmacology and therapeutics 2006;80(4):307-18.
2006: Margalida Rotger; Chantal Csajka; Amalio Telenti
Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents.
Current HIV/AIDS reports 2006;3(3):118-25.
2006: Arman Bashirova; Gabriela Bleiber; Ying Qi; Holli B Hutcheson; Traci Yamashita; Randall C Johnson; Jie Cheng; Galit Alter; James J Goedert; Susan Buchbinder; Keith Hoots; David Vlahov; Margaret May; Frank Maldarelli; Lisa P Jacobson; Stephen J O'Brien; Amalio Telenti; Mary Carrington
Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1.
Journal of virology 2006;80(14):6757-63.
2006: Sara Colombo; Amalio Telenti; Thierry Buclin; Hansjakob Furrer; Belle L Lee; Jérôme Biollaz; Laurent A Decosterd
Are plasma levels valid surrogates for cellular concentrations of antiretroviral drugs in HIV-infected patients?
Therapeutic drug monitoring 2006;28(3):332-8.
2006: Amalio Telenti
Host polymorphism in steps of the HIV-1 lifecycle after entry and other genetic variants influencing HIV-1 pathogenesis.
Current opinion in HIV and AIDS 2006;1(3):232-40.
2006: Viktor Müller; bruno ledergerber; Luc Perrin; Thomas Klimkait; Hansjakob Furrer; Amalio Telenti; Enos Bernasconi; Pietro Vernazza; Huldrych Günthard; Sebastian Bonhoeffer
Stable virulence levels in the HIV epidemic of Switzerland over two decades.
AIDS (London, England) 2006;20(6):889-94.
2006: Sara Colombo; A Béguin; Catia Marzolini; Amalio Telenti; Jérôme Biollaz; Laurent A Decosterd
Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC-UV after solid-phase extraction.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2006;832(1):138-43.
2006: Valérie Goldschmidt; Gabriela Bleiber; Margaret May; Raquel Martinez; Millan Ortiz; Amalio Telenti
Role of common human TRIM5alpha variants in HIV-1 disease progression.
Retrovirology 2006;3():54.
2006: Yasuo Ariumi; Fatima Serhan; Priscilla Turelli; Amalio Telenti; Didier Trono
The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription.
Retrovirology 2006;3():47.
2006: Sara Colombo; Thierry Buclin; Claudia Franc; Nicole Guignard; Mona Khonkarly; Philip E Tarr; Bertrand Rochat; Jérôme Biollaz; Amalio Telenti; Laurent A Decosterd; Matthias Cavassini
Ritonavir-boosted atazanavir-lopinavir combination: a pharmacokinetic interaction study of total, unbound plasma and cellular exposures.
Antiviral therapy 2006;11(1):53-62.
2006: Millan Ortiz; Gabriela Bleiber; Raquel Martinez; Henrik Kaessmann; Amalio Telenti
Patterns of evolution of host proteins involved in retroviral pathogenesis.
Retrovirology 2006;3():11.
2006: Amalio Telenti; John Ioannidis
Susceptibility to HIV infection--disentangling host genetics and host behavior.
The Journal of infectious diseases 2006;193(1):4-6.
2005: Margalida Rotger; Patrick Taffe; Gabriela Bleiber; Huldrych F Gunthard; Hansjakob Furrer; Pietro Vernazza; Henning Drechsler; Enos Bernasconi; Martin Rickenbach; Amalio Telenti
Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia.
The Journal of infectious diseases 2005;192(8):1381-6.
2005: Victoria A Johnson; Françoise Brun Vezinet; Bonaventura Clotet; Brian Conway; Daniel R Kuritzkes; Deenan Pillay; Jonathan M Schapiro; Amalio Telenti; Douglas D Richman
Update of the drug resistance mutations in HIV-1: Fall 2005.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2005;13(4):125-31.
2005: Gabriela Bleiber; Margaret May; Raquel Martinez; Pascal R A Meylan; Jürg Ott; Jacques Beckmann; Amalio Telenti
Use of a combined ex vivo/in vivo population approach for screening of human genes involved in the human immunodeficiency virus type 1 life cycle for variants influencing disease progression.
Journal of virology 2005;79(20):12674-80.
2005: Amalio Telenti
Adaptation, co-evolution, and human susceptibility to HIV-1 infection.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2005;5(4):327-34.
2005: Sara Colombo; Nicole Soranzo; Margalida Rotger; Raimund Sprenger; Gabriela Bleiber; Hansjakob Furrer; Thierry Buclin; David Goldstein; Laurent A Décosterd; Amalio Telenti
Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo.
Pharmacogenetics and genomics 2005;15(9):599-608.
2005: Sara Colombo; A Beguin; Amalio Telenti; Jérôme Biollaz; Thierry Buclin; Bertrand Rochat; Laurent A Decosterd
Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2005;819(2):259-76.
2005: Philip E Tarr; Patrick Taffé; Gabriela Bleiber; Hansjakob Furrer; Margalida Rotger; Raquel Martinez; Bernard Hirschel; Manuel Battegay; Rainer Weber; Pietro Vernazza; Enos Bernasconi; Roger Darioli; Martin Rickenbach; bruno ledergerber; Amalio Telenti
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
The Journal of infectious diseases 2005;191(9):1419-26.
2005: Victoria A Johnson; Françoise Brun Vezinet; Bonaventura Clotet; Brian Conway; Daniel R Kuritzkes; Deenan Pillay; Jonathan M Schapiro; Amalio Telenti; Douglas Richman
Update of the Drug Resistance Mutations in HIV-1: 2005.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2005;13(1):51-7.
2005: Jacques Fellay; Catia Marzolini; Laurent A Decosterd; Kerry Powell Golay; Pierre Baumann; Thierry Buclin; Amalio Telenti; Chin B Eap
Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients.
European journal of clinical pharmacology 2005;60(12):865-73.
2005: David Dalmau; Thomas Klimkait; Amalio Telenti
Opinion paper. Resistance to new anti-HIV agents: problems in the pathway of drug registration.
Antiviral therapy 2005;10(7):867-72.
2005: Margalida Rotger; Sara Colombo; Hansjakob Furrer; Gabriela Bleiber; Thierry Buclin; Belle L Lee; Olivia Keiser; Jérôme Biollaz; Laurent A Décosterd; Amalio Telenti
Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients.
Pharmacogenetics and genomics 2005;15(1):1-5.
2004: Sara Colombo; N Guignard; Catia Marzolini; Amalio Telenti; Jérôme Biollaz; Laurent A Decosterd
Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2004;810(1):25-34.
2004: Victoria A Johnson; Françoise Brun-Vézinet; Bonaventura Clotet; Brian Conway; Richard T D'Aquila; Lisa M Demeter; Daniel R Kuritzkes; Deenan Pillay; Jonathan M Schapiro; Amalio Telenti; Douglas D Richman
Update of the drug resistance mutations in HIV-1: 2004.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2004;12(4):119-24.
2004: Ping An; Gabriela Bleiber; Priya Duggal; George Nelson; Margaret May; Bastien Mangeat; Irene Alobwede; Didier Trono; David Vlahov; Sharyne Donfield; James J Goedert; John Phair; Susan Buchbinder; Stephen J O'Brien; Amalio Telenti; Cheryl A Winkler
APOBEC3G genetic variants and their influence on the progression to AIDS.
Journal of virology 2004;78(20):11070-6.
2004: Angela Ciuffi; Gabriela Bleiber; Miguel Muñoz; Raquel Martinez; Corinne Loeuillet; Manuela Rehr; Marek Fischer; Huldrych Günthard; Annette Oxenius; Pascal R A Meylan; Sebastian Bonhoeffer; Didier Trono; Amalio Telenti
Entry and transcription as key determinants of differences in CD4 T-cell permissiveness to human immunodeficiency virus type 1 infection.
Journal of virology 2004;78(19):10747-54.
2004: Chantal Csajka; Catia Marzolini; Karin Fattinger; Laurent A Décosterd; Amalio Telenti; Jérôme Biollaz; Thierry Buclin
Population pharmacokinetics of indinavir in patients infected with human immunodeficiency virus.
Antimicrobial agents and chemotherapy 2004;48(9):3226-32.
2004: Martin Hersberger; Sebastian Bonhoeffer; S K Rampini; Milos Opravil; Jacqueline Marti-Jaun; Amalio Telenti; Edgar Hänseler; bruno ledergerber; Roberto F Speck
CCTTT-repeat polymorphism of the inducible nitric oxide synthase is not associated with HIV pathogenesis.
Clinical and experimental immunology 2004;137(3):566-9.
2004: Andrew M Hill; Amalio Telenti
HIV susceptibility testing--time for standards.
Antiviral therapy 2004;9(4):463-4.
2004: Christian Felley; Michael A Morris; Ambroise Wonkam; Bernard Hirschel; Markus Flepp; Katja Wolf; Hansjakob Furrer; Manuel Battegay; Enos Bernasconi; Amalio Telenti; Jean-Louis Frossard
The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case-control study.
AIDS (London, England) 2004;18(11):1521-7.
2004: Sabine Yerly; Stéphanie Jost; Martine Monnat; Amalio Telenti; Matthias Cavassini; Jean-Philippe Chave; Laurent Kaiser; Philippe Burgisser; Luc Perrin
HIV-1 co/super-infection in intravenous drug users.
AIDS (London, England) 2004;18(10):1413-21.
2004: Sabine Yerly; Stéphanie Jost; Amalio Telenti; Markus Flepp; Laurent Kaiser; Jean-Philippe Chave; Pietro Vernazza; Manuel Battegay; Hansjakob Furrer; Bruno Chanzy; Philippe Burgisser; Martin Rickenbach; Martin Gebhardt; Marie-Charlotte Bernard; Thomas Perneger; Bernard Hirschel; Luc Perrin
Infrequent transmission of HIV-1 drug-resistant variants.
Antiviral therapy 2004;9(3):375-84.
2004: Amalio Telenti
The genetic cohorts: facing the new challenges in infectious diseases. The HIV model.
Enfermedades infecciosas y microbiología clínica 2004;22(6):337-41.
2004: Chin B Eap; Thierry Buclin; Elisabeth Hustert; Gabriela Bleiber; Kerry Powell Golay; Anne-Catherine Aubert; Pierre Baumann; Amalio Telenti; Reinhold Kerb
Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects.
European journal of clinical pharmacology 2004;60(4):231-6.
2004: Chin B Eap; Thierry Buclin; Gianni Cucchia; Daniele Fabio Zullino; Elisabeth Hustert; Gabriela Bleiber; Kerry Powell Golay; Anne-Catherine Aubert; Pierre Baumann; Amalio Telenti; Reinhold Kerb
Oral administration of a low dose of midazolam (75 microg) as an in vivo probe for CYP3A activity.
European journal of clinical pharmacology 2004;60(4):237-46.
2004: Angela Ciuffi; Miguel Munoz; Gabriela Bleiber; Manuel Favre; Françoise Stutz; Amalio Telenti; Pascal R A Meylan
Interactions of processed Nef (58-206) with virion proteins of HIV type 1.
AIDS research and human retroviruses 2004;20(4):399-407.
2004: Chin B Eap; Jacques Fellay; Thierry Buclin; Gabriela Bleiber; Kerry Powell Golay; Murielle Brocard; Pierre Baumann; Amalio Telenti
CYP3A activity measured by the midazolam test is not related to 3435 C >T polymorphism in the multiple drug resistance transporter gene.
Pharmacogenetics 2004;14(4):255-60.
2004: Gabriela Bleiber; Solange Peters; Raquel Martinez; Dusan Cmarko; Pascal R A Meylan; Amalio Telenti
The central region of human immunodeficiency virus type 1 p6 protein (Gag residues S14-I31) is dispensable for the virus in vitro.
The Journal of general virology 2004;85(Pt 4):921-7.
2004: Gabriela Bleiber; Margaret May; Carlos Suarez; Raquel Martinez; Catia Marzolini; Matthias Egger; Amalio Telenti
MDR1 genetic polymorphism does not modify either cell permissiveness to HIV-1 or disease progression before treatment.
The Journal of infectious diseases 2004;189(4):583-6.
2004: Amalio Telenti
Polymorphisms, resistance and drug response: beyond subtype-B HIV-1.
Antiviral therapy 2004;9(1):1.
2004: Sophie Guyot; Daniel Hayoz; Amalio Telenti; Matthias Cavassini
Peripheral oedema and high arterial blood flow as a complication of antiretroviral therapy.
AIDS (London, England) 2004;18(2):356-8.
2004: Jim Young; Sabina De Geest; Rebecca Spirig; Markus Flepp; Martin Rickenbach; Hansjakob Furrer; Enos Bernasconi; Bernard Hirschel; Amalio Telenti; Pietro Vernazza; Manuel Battegay; Heiner C Bucher
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study.
BMJ (Clinical research ed.) 2004;328(7430):15.
2003: Alexandra Trkola; Herbert Kuster; Christine Leemann; Claudia Ruprecht; Beda Joos; Amalio Telenti; Bernard Hirschel; Rainer Weber; Sebastian Bonhoeffer; Huldrych Günthard
Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infection.
Journal of virology 2003;77(24):13146-55.
2003: Victoria A Johnson; Françoise Brun-Vézinet; Bonaventura Clotet; Brian Conway; Richard T D'Aquila; Lisa M Demeter; Daniel R Kuritzkes; Deenan Pillay; Jonathan M Schapiro; Amalio Telenti; Douglas D Richman
Drug resistance mutations in HIV-1.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2003;11(6):215-21.
2003: Gilbert R Kaufmann; Luc Perrin; Guiseppe Pantaleo; Milos Opravil; Hansjakob Furrer; Amalio Telenti; Bernard Hirschel; bruno ledergerber; Pietro Vernazza; Enos Bernasconi; Martin Rickenbach; Matthias Egger; Manuel Battegay
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Archives of internal medicine 2003;163(18):2187-95.
2003: Christophe Butticaz; Angela Ciuffi; Miguel Muñoz; Jérôme Thomas; Alan Bridge; Stephanie Pebernard; Richard D Iggo; Pascal R A Meylan; Amalio Telenti
Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression.
Antiviral therapy 2003;8(5):373-7.
2003: Manuel Favre; Christophe Butticaz; Brian Stevenson; Victor Jongeneel; Amalio Telenti
High frequency of alternative splicing of human genes participating in the HIV-1 life cycle: a model using TSG101, betaTrCP, PPIA, INI1, NAF1, and PML.
Journal of acquired immune deficiency syndromes (1999) 2003;34(2):127-33.
2003: Christian Jaggy; Jan von Overbeck; bruno ledergerber; Claude Schwarz; Matthias Egger; Martin Rickenbach; Hans-Jakob Furrer; Amalio Telenti; Manuel Battegay; Markus Flepp; Pietro Vernazza; Enos Bernasconi; Bernard Hirschel
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population.
Lancet 2003;362(9387):877-8.
2003: Katja Wolf; Jim Young; Martin Rickenbach; Pietro Vernazza; Markus Flepp; Hansjakob Furrer; Enos Bernasconi; Bernard Hirschel; Amalio Telenti; Rainer Weber; Heiner C Bucher
Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study.
Journal of acquired immune deficiency syndromes (1999) 2003;33(4):494-9.
2003: Catherine Fagard; Michelle Le Braz; Huldrych Günthard; Hans Hirsch; Martin Egger; Pietro Vernazza; Enos Bernasconi; Amalio Telenti; Corinna Ebnöther; Annette Oxenius; Thomas Perneger; Luc Perrin; Bernard Hirschel
A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART.
AIDS (London, England) 2003;17(10):1487-92.
2003: Catherine Fagard; Annette Oxenius; Huldrych Günthard; Felipe Garcia; Michelle Le Braz; Gabriel Mestre; Manuel Battegay; Hansjakob Furrer; Pietro Vernazza; Enos Bernasconi; Amalio Telenti; Rainer Weber; Dominique Leduc; Sabine Yerly; David Price; Sara J Dawson; Thomas Klimkait; Thomas V Perneger; Angela McLean; Bonaventura Clotet; José M Gatell; Luc Perrin; Montserrat Plana; Rodney Phillips; Bernard Hirschel
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.
Archives of internal medicine 2003;163(10):1220-6.
2003: Amalio Telenti
[The present and future of clinical virology].
Enfermedades infecciosas y microbiología clínica 2003;21 Suppl 2():81-3.
2003: Christina Eigenmann; Markus Flepp; Enos Bernasconi; Veronique Schiffer; Amalio Telenti; Heiner C Bucher; Thomas Wagels; Matthias Egger; Hansjakob Furrer
Low incidence of community-acquired pneumonia among human immunodeficiency virus-infected patients after interruption of Pneumocystis carinii pneumonia prophylaxis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(7):917-21.
2003: Caroline Taillard; Gilbert Greub; Rainer Weber; Gaby E Pfyffer; Thomas Bodmer; Stefan Zimmerli; Reno Frei; Stefano Bassetti; Peter Rohner; Jean-Claude Piffaretti; Enos Bernasconi; Jacques Bille; Amalio Telenti; Guy Prod'hom
Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey.
Journal of clinical microbiology 2003;41(3):1240-4.
2003: Chantal Csajka; Catia Marzolini; Karin Fattinger; Laurent A Décosterd; Jacques Fellay; Amalio Telenti; Jérôme Biollaz; Thierry Buclin
Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection.
Clinical pharmacology and therapeutics 2003;73(1):20-30.
2002: Heiner C Bucher; M Bichsel; Patrick Taffé; Hansjakob Furrer; Amalio Telenti; Bernard Hirschel; Rainer Weber; Enos Bernasconi; Pietro Vernazza; Christoph Minder; Manuel Battegay
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study.
HIV medicine 2002;3(4):247-53.
2002: Nicole Doser; Sandrine Kübli; Amalio Telenti; Catia Marzolini; Jean-Philippe Chave; François Feihl; Thierry Buclin; André Pannatier; Roger Darioli; Pascal Nicod; Bernard Waeber; Vincent Mooser
Efficacy and safety of fluvastatin in hyperlipidemic protease inhibitor-treated HIV-infected patients.
AIDS (London, England) 2002;16(14):1982-3.
2002: Gilbert Greub; Alessandro Cozzi-Lepri; bruno ledergerber; Schlomo Staszewski; Luc Perrin; Veronica Miller; Patrick Francioli; Hansjakob Furrer; Manuel Battegay; Pietro Vernazza; Enos Bernasconi; Huldrych Günthard; Bernard Hirschel; Andrew N Phillips; Amalio Telenti
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy.
AIDS (London, England) 2002;16(14):1967-9.
2002: Enos Bernasconi; karim boubaker; Cornelia Junghans; Markus Flepp; Hansjakob Furrer; Alexander Haensel; Bernard Hirschel; Katia Boggian; Jean-Philippe Chave; Milos Opravil; Rainer Weber; Martin Rickenbach; Amalio Telenti
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study.
Journal of acquired immune deficiency syndromes (1999) 2002;31(1):50-5.
2002: Alexandre Harari; G Paolo Rizzardi; Kim Ellefsen; Donatella Ciuffreda; Patrick Champagne; Pierre-Alexandre Bart; Daniel Kaufmann; Amalio Telenti; Roland Sahli; Giuseppe Tambussi; Laurent Kaiser; Adriano Lazzarin; Luc Perrin; Giuseppe Pantaleo
Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection.
Blood 2002;100(4):1381-7.
2002: Amalio Telenti; Raquel Martinez; Miguel Munoz; Gabriela Bleiber; Gilbert Greub; Dominique Sanglard; Solange Peters
Analysis of natural variants of the human immunodeficiency virus type 1 gag-pol frameshift stem-loop structure.
Journal of virology 2002;76(15):7868-73.
2002: Catia Marzolini; A Béguin; Amalio Telenti; A Schreyer; Thierry Buclin; Jérôme Biollaz; Laurent A Decosterd
Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction: application for the assessment of their transplacental passage at delivery.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2002;774(2):127-40.
2002: Gilbert Greub; Serge Gallant; Pascal Zurn; Marco Vannotti; Philippe Bürgisser; Patrick Francioli; Giorgio Zanetti; Amalio Telenti
Spare non-occupational HIV post-exposure prophylaxis by active contacting and testing of the source person.
AIDS (London, England) 2002;16(8):1171-6.
2002: Catia Marzolini; Christoph Rudin; Laurent A Decosterd; Amalio Telenti; Alain Schreyer; Jérôme Biollaz; Thierry Buclin
Transplacental passage of protease inhibitors at delivery.
AIDS (London, England) 2002;16(6):889-93.
2002: Amalio Telenti; Vincent Aubert; François Spertini
Individualising HIV treatment--pharmacogenetics and immunogenetics.
Lancet 2002;359(9308):722-3.
2002: Bernard Hirschel; Markus Flepp; Heiner C Bucher; Claudine Zellweger; Amalio Telenti; Thomas Wagels; Enos Bernasconi; bruno ledergerber
Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case-control study from the Swiss HIV Cohort.
AIDS (London, England) 2002;16(3):381-5.
2002: Gilbert Greub; Jacques Fellay; Amalio Telenti
HIV lipoatrophy and mosquito bites.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(2):288-9.
2002: Jacques Fellay; Catia Marzolini; E Rhiannon Meaden; David J Back; Thierry Buclin; Jean-Philippe Chave; Laurent A Decosterd; Hansjakob Furrer; Milos Opravil; Giuseppe Pantaleo; Dorota Retelska; Lidia Ruiz; Alfred H Schinkel; Pietro Vernazza; Chin B Eap; Amalio Telenti
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.
Lancet 2002;359(9300):30-6.
2001: Gilbert Greub; A Maziéro; Philippe Bürgisser; Amalio Telenti; Patrick Francioli
Spare post-exposure prophylaxis with round-the-clock HIV testing of the source patient.
AIDS (London, England) 2001;15(18):2451-2.
2001: karim boubaker; Markus Flepp; P Sudre; Hansjakob Furrer; A Haensel; Bernard Hirschel; Katia Boggian; Jean-Philippe Chave; Enos Bernasconi; Matthias Egger; Milos Opravil; Martin Rickenbach; Patrick Francioli; Amalio Telenti
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(11):1931-7.
2001: Sabine Yerly; Samir Vora; PG Rizzardi; Jean-Philippe Chave; Pietro L Vernazza; Markus Flepp; Amalio Telenti; Manuel Battegay; A L Veuthey; Jean Pierre Bru; Martin Rickenbach; Bernard Hirschel; Luc Perrin
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance.
AIDS (London, England) 2001;15(17):2287-92.
2001: Catia Marzolini; Jean-Philippe Chave; Amalio Telenti; L Brenas-Chinchon; Jérôme Biollaz
Impaired absorption of rifabutin by concomitant administration of didanosine.
AIDS (London, England) 2001;15(16):2203-4.
2001: Jacques Fellay; karim boubaker; bruno ledergerber; Enos Bernasconi; Hansjakob Furrer; M Battegay; Bernard Hirschel; Pietro Vernazza; Patrick Francioli; Gilbert Greub; Markus Flepp; Amalio Telenti
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study.
Lancet 2001;358(9290):1322-7.
2001: S Peters; M Muñoz; Sabine Yerly; Victor Sanchez-Merino; Cecilio Lopez-Galindez; Luc Perrin; B Larder; Dusan Cmarko; Stanislav Fakan; Pascal R A Meylan; Amalio Telenti
Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein.
Journal of virology 2001;75(20):9644-53.
2001: A C Friedl; bruno ledergerber; Markus Flepp; Bernard Hirschel; Amalio Telenti; Hansjakob Furrer; Heiner C Bucher; Enos Bernasconi; Rainer Weber
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study.
AIDS (London, England) 2001;15(14):1793-800.
2001: M Rossi; Markus Flepp; Amalio Telenti; Veronique Schiffer; Niklaus Egloff; Heiner C Bucher; Pietro Vernazza; Enos Bernasconi; R Weber; Martin Rickenbach; Hansjakob Furrer
Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy.
Swiss medical weekly 2001;131(31-32):471-7.
2001: Catia Marzolini; Thierry Buclin; Laurent A Decosterd; Jérôme Biollaz; Amalio Telenti
Nelfinavir plasma levels under twice-daily and three-times-daily regimens: high interpatient and low intrapatient variability.
Therapeutic drug monitoring 2001;23(4):394-8.
2001: Nicole Doser; P Sudre; Amalio Telenti; Vincent Wietlisbach; Pascal Nicod; Roger Darioli; Vincent Mooser
Persistent dyslipidemia in HIV-infected individuals switched from a protease inhibitor-containing to an efavirenz-containing regimen.
Journal of acquired immune deficiency syndromes (1999) 2001;26(4):389-90.
2001: Gabriela Bleiber; Miguel Munoz; Angela Ciuffi; Pascal R A Meylan; Amalio Telenti
Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1.
Journal of virology 2001;75(7):3291-300.
2001: Hansjakob Furrer; Milos Opravil; M Rossi; Enos Bernasconi; Amalio Telenti; Heiner C Bucher; Veronique Schiffer; Katia Boggian; Martin Rickenbach; Markus Flepp; Matthias Egger
Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study.
AIDS (London, England) 2001;15(4):501-7.
2001: Michèle Depairon; S Chessex; P Sudre; Nicolas Rodondi; Nicole Doser; Jean-Philippe Chave; Walter Riesen; Pascal Nicod; Roger Darioli; Amalio Telenti; Vincent Mooser
Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy.
AIDS (London, England) 2001;15(3):329-34.
2001: Catia Marzolini; Amalio Telenti; Laurent A Decosterd; G Greub; Jérôme Biollaz; Thierry Buclin
Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients.
AIDS (London, England) 2001;15(1):71-5.
2000: Gilbert Greub; bruno ledergerber; Manuel Battegay; P Grob; Luc Perrin; Hansjakob Furrer; Philippe Burgisser; Peter Erb; Katia Boggian; Jean-Claude Piffaretti; Bernard Hirschel; Pascal Janin; Patrick Francioli; Markus Flepp; Amalio Telenti
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.
Lancet 2000;356(9244):1800-5.
2000: Olivier T Rutschmann; Pietro L Vernazza; Heiner C Bucher; Milos Opravil; bruno ledergerber; Amalio Telenti; RP Malinverni; Enos Bernasconi; Catherine Fagard; Dominique Leduc; Luc Perrin; Bernard Hirschel
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study.
AIDS (London, England) 2000;14(14):2145-51.
2000: Frank Bally; R Martinez; S Peters; P Sudre; Amalio Telenti
Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors.
AIDS research and human retroviruses 2000;16(13):1209-13.
2000: D Kaufmann; M Muñoz; Gabriela Bleiber; Sylvain Fleury; B Lotti; R Martinez; W Pichler; Pascal R A Meylan; Amalio Telenti
Virological and immunological characteristics of HIV treatment failure.
AIDS (London, England) 2000;14(12):1767-74.
2000: Hansjakob Furrer; Amalio Telenti; M Rossi; bruno ledergerber
Discontinuing or withholding primary prophylaxis against Mycobacterium avium in patients on successful antiretroviral combination therapy. The Swiss HIV Cohort Study.
AIDS (London, England) 2000;14(10):1409-12.
2000: Catia Marzolini; N Troillet; Amalio Telenti; P Baumann; Laurent A Decosterd; Chin B Eap
Efavirenz decreases methadone blood concentrations.
AIDS (London, England) 2000;14(9):1291-2.
2000: N Khanna; Thomas Klimkait; Veronique Schiffer; J Irigoyen; Amalio Telenti; Bernard Hirschel; Manuel Battegay
Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort Study.
AIDS (London, England) 2000;14(7):791-9.
2000: Catia Marzolini; Amalio Telenti; Thierry Buclin; Jérôme Biollaz; Laurent A Decosterd
Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction.
Journal of chromatography. B, Biomedical sciences and applications 2000;740(1):43-58.
2000: Amalio Telenti; M Iseman
Drug-resistant tuberculosis: what do we do now?
Drugs 2000;59(2):171-9.
2000: AS Piatek; Amalio Telenti; M R Murray; Hiyam El-Hajj; William R. Jacobs Jr.; Fred Kramer; David Alland
Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing.
Antimicrobial agents and chemotherapy 2000;44(1):103-10.
1999: bruno ledergerber; Matthias Egger; V Erard; Rainer Weber; Bernard Hirschel; Hansjakob Furrer; Manuel Battegay; Pietro Vernazza; Enos Bernasconi; Milos Opravil; D Kaufmann; P Sudre; Patrick Francioli; Amalio Telenti
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
JAMA : the journal of the American Medical Association 1999;282(23):2220-6.
1999: Amalio Telenti; Frank Bally
HIV epidemiology and treatment - 1999.
Ocular immunology and inflammation 1999;7(3-4):129-32.
1999: Margarete Borg-Von Zepelin; I Meyer; R Thomssen; Reinhard Wurzner; Dominique Sanglard; Amalio Telenti; Michel Monod
HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases.
The Journal of investigative dermatology 1999;113(5):747-51.
1999: D Périard; Amalio Telenti; P Sudre; Jean-Jacques Cheseaux; P Halfon; M J Reymond; S M Marcovina; Michel-Pierre Glauser; Pascal Nicod; Roger Darioli; Vincent Mooser
Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study.
Circulation 1999;100(7):700-5.
1999: bruno ledergerber; Amalio Telenti; Matthias Egger
Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study.
BMJ (Clinical research ed.) 1999;319(7201):23-4.
1999: S Bassetti; Manuel Battegay; Hansjakob Furrer; M Rickenbach; Markus Flepp; L Kaiser; Amalio Telenti; Pietro L Vernazza; Enos Bernasconi; P Sudre
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study.
Journal of acquired immune deficiency syndromes (1999) 1999;21(2):114-9.
1999: Hansjakob Furrer; Matthias Egger; Milos Opravil; Enos Bernasconi; Bernard Hirschel; Manuel Battegay; Amalio Telenti; Pietro L Vernazza; Martin Rickenbach; Markus Flepp; RP Malinverni
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.
The New England journal of medicine 1999;340(17):1301-6.
1999: bruno ledergerber; Matthias Egger; Milos Opravil; Amalio Telenti; Bernard Hirschel; Manuel Battegay; Pietro Vernazza; P Sudre; Markus Flepp; Hansjakob Furrer; Patrick Francioli; Rainer Weber
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study.
Lancet 1999;353(9156):863-8.
1999: Michel Monod; Margarete Borg-Von Zepelin; Amalio Telenti; Dominique Sanglard
The inhibition of Candida-albicans-secreted aspartic proteases by three different HIV protease inhibitors.
Dermatology (Basel, Switzerland) 1999;198(4):412-4.
1998: karim boubaker; P Sudre; Frank Bally; G Vogel; Jean-Yves Meuwly; Michel-Pierre Glauser; Amalio Telenti
Changes in renal function associated with indinavir.
AIDS (London, England) 1998;12(18):F249-54.
1998: Amalio Telenti
Genetics and pulmonary medicine. 5. Genetics of drug resistant tuberculosis.
Thorax 1998;53(9):793-7.
1998: L Perrin; Amalio Telenti
HIV treatment failure: testing for HIV resistance in clinical practice.
Science (New York, N.Y.) 1998;280(5371):1871-3.
1998: WJ Philipp; D C Schwartz; Amalio Telenti; Stewart T Cole
Mycobacterial genome structure.
Electrophoresis 1998;19(4):573-6.
1998: AS Piatek; Sanjay Tyagi; A C Pol; Amalio Telenti; L P Miller; Fred Kramer; David Alland
Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis.
Nature biotechnology 1998;16(4):359-63.
1998: D Kaufmann; G Pantaleo; P Sudre; Amalio Telenti
CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study.
Lancet 1998;351(9104):723-4.
1998: Peter Sander; F Alcaide; I Richter; K Frischkorn; ENRICO TORTOLI; Burkhard Springer; Amalio Telenti; Erik C Böttger
Inteins in mycobacterial GyrA are a taxonomic character.
Microbiology (Reading, England) 1998;144 ( Pt 2)():589-91.
1998: Amalio Telenti; Nadine Honoré; Stewart T Cole
Detection of mutations in mycobacteria by PCR-SSCP (single-strand conformation polymorphism).
Methods in molecular biology (Clifton, N.J.) 1998;101():423-30.
1998: WJ Philipp; S Gordon; Amalio Telenti; Stewart T Cole
Pulsed field gel electrophoresis for mycobacteria.
Methods in molecular biology (Clifton, N.J.) 1998;101():51-63.
1997: Philippe M Hauser; Patrick Francioli; Jacques Bille; Amalio Telenti; Dominique Blanc
Typing of Pneumocystis carinii f. sp. hominis by single-strand conformation polymorphism of four genomic regions.
Journal of clinical microbiology 1997;35(12):3086-91.
1997: Philippe M Hauser; Patrick Francioli; Jacques Bille; Amalio Telenti; Dominique Blanc
Typing of Pneumocystis carinii sp.f. hominis by PCR-SSCP of four genomic regions.
The Journal of eukaryotic microbiology 1997;44(6):16S.
1997: Amalio Telenti; Maurice W Southworth; F Alcaide; S Daugelat; William R. Jacobs Jr.; Francine B Perler
The Mycobacterium xenopi GyrA protein splicing element: characterization of a minimal intein.
Journal of bacteriology 1997;179(20):6378-82.
1997: F Alcaide; Gaby E Pfyffer; Amalio Telenti
Role of embB in natural and acquired resistance to ethambutol in mycobacteria.
Antimicrobial agents and chemotherapy 1997;41(10):2270-3.
1997: F Alcaide; Amalio Telenti
Molecular techniques in the diagnosis of drug-resistant tuberculosis.
Annals of the Academy of Medicine, Singapore 1997;26(5):647-50.
1997: Srinand Sreevtsan; KE Stockbauer; Xi Pan; Barry N Kreiswirth; Soraya L Moghazeh; William R. Jacobs Jr.; Amalio Telenti; James M Musser
Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations.
Antimicrobial agents and chemotherapy 1997;41(8):1677-81.
1997: F Alcaide; I Richter; C Bernasconi; Burkhard Springer; C Hagenau; Roland Schulze-Röbbecke; ENRICO TORTOLI; R Martín; Erik C Böttger; Amalio Telenti
Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies.
Journal of clinical microbiology 1997;35(8):1959-64.
1997: Amalio Telenti; WJ Philipp; Srinand Sreevtsan; C Bernasconi; KE Stockbauer; B Wieles; James M Musser; William R. Jacobs Jr.
The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol.
Nature medicine 1997;3(5):567-70.
1997: Amalio Telenti; Nadine Honoré; C Bernasconi; J March; A Ortega; B Heym; H E Takiff; Stewart T Cole
Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level.
Journal of clinical microbiology 1997;35(3):719-23.
1997: Philippe M Hauser; Dominique Blanc; Jacques Bille; Amalio Telenti; Patrick Francioli
Development of a molecular typing method for Pneumocystis carinii sp.f. hominis.
APMIS. Supplementum 1997;77():7-10.
1996: Philippe M Hauser; Dominique Blanc; Jacques Bille; Amalio Telenti; Patrick Francioli
Development of a molecular typing method for Pneumocystis carinii sp.f. hominis.
The Journal of eukaryotic microbiology 1996;43(5):34S.
1996: Burkhard Springer; W K Wu; Thomas Bodmer; Gerhard Haase; Gaby E Pfyffer; Reiner M Kroppenstedt; K H Schröder; S Emler; J O Kilburn; Philip Kirschner; Amalio Telenti; M B Coyle; Erik C Böttger
Isolation and characterization of a unique group of slowly growing mycobacteria: description of Mycobacterium lentiflavum sp. nov.
Journal of clinical microbiology 1996;34(5):1100-7.
1996: Amalio Telenti; D H Persing
Novel strategies for the detection of drug resistance in Mycobacterium tuberculosis.
Research in microbiology 1996;147(1-2):73-9.
1995: Thomas Bodmer; Amalio Telenti; K Schopfer; Lukas Matter
[Current developments in Mycobacteria diagnosis].
Schweizerische medizinische Wochenschrift 1995;125(37):1726-34.
1995: D R Burki; C Bernasconi; Thomas Bodmer; Amalio Telenti
Evaluation of the relatedness of strains of Mycobacterium avium using pulsed-field gel electrophoresis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1995;14(3):212-7.
1995: Vivek Kapur; L L Li; M R Hamrick; Bonnie B Plikaytis; Thomas M Shinnick; Amalio Telenti; William R. Jacobs Jr.; A Banerjee; S Cole; K Y Yuen
Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing.
Archives of pathology & laboratory medicine 1995;119(2):131-8.
1995: Thomas Bodmer; G Zürcher; P Imboden; Amalio Telenti
Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis.
The Journal of antimicrobial chemotherapy 1995;35(2):345-8.
1995: C Guerrero; C Bernasconi; D Burki; Thomas Bodmer; Amalio Telenti
A novel insertion element from Mycobacterium avium, IS1245, is a specific target for analysis of strain relatedness.
Journal of clinical microbiology 1995;33(2):304-7.
1995: M Bono; T Jemmi; C Bernasconi; D Burki; Amalio Telenti; Thomas Bodmer
Genotypic characterization of Mycobacterium avium strains recovered from animals and their comparison to human strains.
Applied and environmental microbiology 1995;61(1):371-3.
1994: V Deiss; Jan von Overbeck; Hansjakob Furrer; D Germann; Lukas Matter; Amalio Telenti
[Epidemiology of HIV-1 infection in Bern--application of molecular methods].
Schweizerische medizinische Wochenschrift 1994;124(13):539-44.
1994: H E Takiff; L Salazar; C Guerrero; W Philipp; W M Huang; B Kreiswirth; Stewart T Cole; William R. Jacobs Jr.; Amalio Telenti
Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations.
Antimicrobial agents and chemotherapy 1994;38(4):773-80.
1994: C Guerrero; L Stockman; F Marchesi; Thomas Bodmer; G D Roberts; Amalio Telenti
Evaluation of the rpoB gene in rifampicin-susceptible and -resistant Mycobacterium avium and Mycobacterium intracellulare.
The Journal of antimicrobial chemotherapy 1994;33(3):661-3.
1993: A Genewein; Amalio Telenti; C Bernasconi; C Mordasini; S Weiss; A M Maurer; H L Rieder; K Schopfer; Thomas Bodmer
Molecular approach to identifying route of transmission of tuberculosis in the community.
Lancet 1993;342(8875):841-4.
1993: Amalio Telenti; P Imboden; F Marchesi; T Schmidheini; Thomas Bodmer
Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis.
Antimicrobial agents and chemotherapy 1993;37(10):2054-8.
1993: Amalio Telenti; Dominik Uehlinger; F Marchesi; D Germann; R Malinverni; Lukas Matter
Epstein-Barr virus infection in HIV-positive patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(8):601-9.
1993: Amalio Telenti; P Imboden; F Marchesi; D Lowrie; S Cole; M J Colston; Lukas Matter; K Schopfer; Thomas Bodmer
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.
Lancet 1993;341(8846):647-50.
1993: Amalio Telenti; F Marchesi; M Balz; Frank Bally; Erik C Böttger; Thomas Bodmer
Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.
Journal of clinical microbiology 1993;31(2):175-8.
1992: Amalio Telenti; P Imboden; D Germann
Competitive polymerase chain reaction using an internal standard: application to the quantitation of viral DNA.
Journal of virological methods 1992;39(3):259-68.
1992: Amalio Telenti; W F Marshall; A J Aksamit; J D Smilack; Thomas F Smith
Detection of JC virus by polymerase chain reaction in cerebrospinal fluid from two patients with progressive multifocal leukoencephalopathy.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1992;11(3):253-4.
1992: Bettina Borisch; Amalio Telenti; I Hennig; F Marchesi; J Audouin; J Diebold; G Pallesen
[The EBNA2 coding region in the viral genome of Epstein-Barr virus (EBV)-positive cases of Hodgkin's disease].
Verhandlungen der Deutschen Gesellschaft für Pathologie 1992;76():181-4.
1991: W F Marshall; Amalio Telenti; J Proper; A J Aksamit; Thomas F Smith
Survey of urine from transplant recipients for polyomaviruses JC and BK using the polymerase chain reaction.
Molecular and cellular probes 1991;5(2):125-8.
1990: Amalio Telenti; W F Marshall; Thomas F Smith
Detection of Epstein-Barr virus by polymerase chain reaction.
Journal of clinical microbiology 1990;28(10):2187-90.
1990: Amalio Telenti; A J Aksamit; J Proper; Thomas F Smith
Detection of JC virus DNA by polymerase chain reaction in patients with progressive multifocal leukoencephalopathy.
The Journal of infectious diseases 1990;162(4):858-61.
1990: W F Marshall; Amalio Telenti; J Proper; A J Aksamit; Thomas F Smith
Rapid detection of polyomavirus BK by a shell vial cell culture assay.
Journal of clinical microbiology 1990;28(7):1613-5.
1989: Amalio Telenti; G D Roberts
Fungal blood cultures.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(9):825-31.